4-[4-（4-氯苯基）-4-羟基-1-哌啶基]-1-（4-氟苯基）-1-丁酮

产品名称：

52-86-8
Haloperidol for system suitability
4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4′-fluorobutyrophenone
Haloperidol
4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4′-fluorobutyrophenone
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
系统适用性试验用氟哌啶醇
4-[4-（4-氯苯基）-4-羟基-1-哌啶基]-1-（4-氟苯基）-1-丁酮
4-[4-（对氯苯基）-4-羟基哌啶基]-4'-氟丁酰苯
氟哌啶醇
4-[4-（4-氯苯基）-4-羟基哌啶基]-4'-氟丁酰苯

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₂₁H₂₃ClFNO₂
分子量	375.86
MDL编号	MFCD00051423
PubChem化学物质编号	329831468
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
储存温度	2-8℃
SMILES string	OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3
InChI	1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
InChI key	LNEPOXFFQSENCJ-UHFFFAOYSA-N
Gene Information	human ... HTR2A(3356)

安全信息

象形图
警示用语：	Danger
危险声明	H301 - H315 - H317 - H319 - H335 - H361
预防措施声明	P201 - P202 - P280 - P301 + P310 - P302 + P352 - P305 + P351 + P338
危险分类	Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
靶器官	Respiratory system
储存分类代码	6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable